SCHEMBL6234556

SCHEMBL6234556

Cc1ccc(S([O])(=O)=O)cc1OS(C)(=O)=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.38
CYP1A2 P05177 1/20 0.38
ALPL P05186 1/20 0.38
HSD17B10 Q99714 1/20 0.38
LMNA P02545 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
POLB P06746 2/20 0.36
MAPK1 P28482 1/20 0.36
CYP4F2 P78329 1/20 0.36
CYP4A11 Q02928 1/20 0.36
KDM4E B2RXH2 2/20 0.35
KMT2A Q03164 1/20 0.35
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34
FFAR4 Q5NUL3 2/20 0.34
ALDH1A1 P00352 5/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
GAA P10253 1/20 0.33
ALOX15 P16050 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14919607 0.80 MAPK1 (0.36) TSHRLMNATDP1POLBMAPK1
SCHEMBL6937345 0.79 CA1 (0.55) TSHRCYP1A2ALPLHSD17B10LMNA
SCHEMBL5739733 0.75 HTR6 (0.48) TSHRLMNATDP1MAPK1KDM4E
SCHEMBL6941469 0.71 TSHR (0.40) TSHRCYP1A2ALPLHSD17B10LMNA
SCHEMBL30821607 0.70 ALDH1A1 (0.45) TSHRCYP1A2ALPLHSD17B10LMNA
SCHEMBL6937363 0.70 ALDH1A1 (0.45) TSHRCYP1A2ALPLHSD17B10LMNA
SCHEMBL12180600 0.69 SMN1; SMN2 (0.61) TSHRLMNAPOLBMAPK1FFAR4
SCHEMBL3631078 0.69 NOTUM (0.55) TSHRHSD17B10TDP1POLBKDM4E
SCHEMBL22187542 0.69 IDH1 (0.49) POLBKMT2ACA1CA2CA9
SCHEMBL29673728 0.69 IDH1 (0.49) POLBKMT2ACA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1534654-A1 METHOD FOR THE SEPARATION OF INTERMEDIATES WHICH MAY BE USED FOR THE PREPARATION OF ESCITALOPRAM H. LUNDBECK A/S (DK) 2005-06-01 EP disclosed
WO-2004014821-A1 METHOD FOR THE SEPARATION OF INTERMEDIATES WHICH MAY BE USED FOR THE PREPARATION OF ESCITALOPRAM H. LUNDBECK A/S (DK) 2004-02-19 WO disclosed
EP-0534667-B1 Tricyclic heterocycles as PGE2 antagonists ZENECA LTD (GB) 1997-02-05 EP disclosed
US-5317101-A Antihyperalgesics IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1994-05-31 US disclosed
EP-0534667-A1 Tricyclic heterocycles as PGE2 antagonists ZENECA LIMITED (GB) 1993-03-31 EP disclosed